AST T. Rowe Price Diversified Real Growth Portfolio is a registered fund series of Advanced Series Trust (series S000045117). Net assets $124.0M as of 2022-12-30.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| PGIM Core Ultra Short Bond Fund | — | $4.5M | 364.38% |
| T Rowe Price Emerging Markets Bond Fund | — | $3.6M | 291.63% |
| T Rowe Price Institutional High Yield Fund | — | $3.5M | 279.82% |
| T Rowe Price Institutional Floating Rate Fund | — | $3.4M | 277.18% |
| TSY INFL IX N/B | — | $3.0M | 243.80% |
| PGIM Institutional Money Market Fund - D | — | $2.9M | 233.10% |
| Microsoft Corp | — | $2.5M | 200.89% |
| Apple Inc | — | $1.8M | 143.98% |
| UnitedHealth Group Inc | — | $1.3M | 102.78% |
| Alphabet Inc | — | $1.3M | 101.76% |
| AstraZeneca PLC | — | $986K | 79.52% |
| TSY INFL IX N/B | — | $974K | 78.56% |
| Visa Inc | — | $965K | 77.86% |
| Chubb Ltd | — | $959K | 77.40% |
| Elevance Health Inc | ELV | $950K | 76.64% |
| Report date | Net assets |
|---|---|
| 2022-12-30 | $124.0M |
| 2022-09-30 | $121.1M |
| 2022-06-30 | $132.4M |
| 2022-03-31 | $155.1M |
| 2021-12-31 | $170.0M |
| 2021-09-30 | $167.2M |
| 2021-06-30 | $170.1M |
| 2021-03-31 | $163.4M |